[HTML][HTML] Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

R Lakhan, R Kumari, K Singh, J Kalita… - Indian Journal of …, 2011 - journals.lww.com
Methods: A total of 402 patients with epilepsy were enrolled in this study; 128 were drug
resistant and 274 were drug responsive. The peripheral blood samples of the patients with …

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

R Lakhan, R Kumari, K Singh, J Kalita… - Indian Journal of …, 2011 - go.gale.com
Background & objectives: Multiple drug resistance in epilepsy is a common problem and
one third of epilepsy patients remain non responsive to antiepileptic drug (AED) therapy. In …

[HTML][HTML] Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

R Lakhan, R Kumari, K Singh, J Kalita… - The Indian Journal of …, 2011 - ncbi.nlm.nih.gov
Methods: A total of 402 patients with epilepsy were enrolled in this study; 128 were drug
resistant and 274 were drug responsive. The peripheral blood samples of the patients with …

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

R Lakhan, R Kumari, K Singh… - The Indian journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Background & objectives Multiple drug resistance in epilepsy is a common problem and one
third of epilepsy patients remain non responsive to antiepileptic drug (AED) therapy. In this …

[PDF][PDF] Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

Indian J Med Res, 2011 - academia.edu
Background & objectives: Multiple drug resistance in epilepsy is a common problem and
one third of epilepsy patients remain non responsive to antiepileptic drug (AED) therapy. In …

[PDF][PDF] Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

Indian J Med Res, 2011 - pdfs.semanticscholar.org
Background & objectives: Multiple drug resistance in epilepsy is a common problem and
one third of epilepsy patients remain non responsive to antiepileptic drug (AED) therapy. In …

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy.

R Lakhan, R Kumari, K Singh, J Kalita… - Indian Journal of …, 2011 - search.ebscohost.com
Background & objectives: Multiple drug resistance in epilepsy is a common problem
and one third of epilepsy patients remain non responsive to antiepileptic drug (AED) …

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy.

R Lakhan, R Kumari, K Singh, J Kalita, UK Misra… - 2011 - pesquisa.bvsalud.org
Background & objectives Multiple drug resistance in epilepsy is a common problem and one
third of epilepsy patients remain non responsive to antiepileptic drug (AED) therapy. In this …

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy.

R Lakhan, R Kumari, K Singh, J Kalita… - The Indian Journal of …, 2011 - europepmc.org
Methods A total of 402 patients with epilepsy were enrolled in this study; 128 were drug
resistant and 274 were drug responsive. The peripheral blood samples of the patients with …

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy

R Lakhan, R Kumari, K Singh, J Kalita… - The Indian Journal …, 2011 - search.proquest.com
Background & objectives: Multiple drug resistance in epilepsy is a common problem and
one third of epilepsy patients remain non responsive to antiepileptic drug (AED) therapy. In …